Skip to content
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
11/10/2020
Expansión: “Cebiotex abre una ronda de 1,6 millones e inicia un ensayo” (Spanish)
You might also be interested in
CEBIOTEX receives approval to initiate a paediatric phase II clinical trial for locally resectable abdominal tumours
We are excited to share that the clinical trial to
Read more
Cebiotex appoints Joan Torrejon as its new CEO
Cebiotex begins a new stage with a change in its
Read more